Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Rivera

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|March 26, 2022
Quantitative NMR for the structural analysis of novel bivalent glycoconjugates as vaccine candidatesAna R Humpierre, Abel Zanuy, Mirelys Saenz, et al.
Chemical Science|January 13, 2022
Direct access to tetrasubstituted cyclopentenyl scaffolds through a diastereoselective isocyanide-based multicomponent reactionVitor A Fernandes, Rafaely N Lima, Yoisel B Broterson, et al.
Angewandte Chemie (International Ed. in English)|January 17, 2020
Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein InteractionsManuel G Ricardo, Ameena M Ali, Jacek Plewka, et al.
Chemical Science|May 3, 2018
Multicomponent polysaccharide-protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidatesYanira Méndez, Janoi Chang, Ana R Humpierre, et al.
Bioconjugate Chemistry|August 19, 2020
Expanding the Scope of Ugi Multicomponent Bioconjugation to Produce Pneumococcal Multivalent Glycoconjugates as Vaccine CandidatesAna R Humpierre, Abel Zanuy, Mirelys Saenz, et al.
Chembiochem : a European Journal of Chemical Biology|October 4, 2024
Effect of O-Acetylation on the Antigenicity and Glycoconjugate Immunogenicity of the Streptococcus Pneumoniae Serotype 7F Capsular PolysaccharideJean-Pierre Soubal, Aloyma Lugo, Darielys Santana-Mederos, et al.
Bioorganic & Medicinal Chemistry|July 22, 2017
KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic libraryJorge González-Bacerio, Sarah El Chamy Maluf, Yanira Méndez, et al.
ACS Central Science|June 2, 2021
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive VaccinesYury Valdes-Balbin, Darielys Santana-Mederos, Françoise Paquet, et al.
International Journal of Biological Macromolecules|January 15, 2025
Development of a StIW111C-based bioresponsive pore-forming conjugate for permeabilizing the endosomal membraneFelipe A Escalona-Rodriguez, Javier La O-Bonet, Lidia Priscila Ferrer Tasies, et al.
European Journal of Medicinal Chemistry|December 14, 2018
Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent solid-phase synthesis of tetrazole-peptidomimeticsYanira Méndez, German De Armas, Idalia Pérez, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Journal of Pharmaceutical and Biomedical Analysis|March 26, 2022
Quantitative NMR for the structural analysis of novel bivalent glycoconjugates as vaccine candidatesAna R Humpierre, Abel Zanuy, Mirelys Saenz, et al.
Chemical Science|January 13, 2022
Direct access to tetrasubstituted cyclopentenyl scaffolds through a diastereoselective isocyanide-based multicomponent reactionVitor A Fernandes, Rafaely N Lima, Yoisel B Broterson, et al.
Angewandte Chemie (International Ed. in English)|January 17, 2020
Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein InteractionsManuel G Ricardo, Ameena M Ali, Jacek Plewka, et al.
Chemical Science|May 3, 2018
Multicomponent polysaccharide-protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidatesYanira Méndez, Janoi Chang, Ana R Humpierre, et al.
Bioconjugate Chemistry|August 19, 2020
Expanding the Scope of Ugi Multicomponent Bioconjugation to Produce Pneumococcal Multivalent Glycoconjugates as Vaccine CandidatesAna R Humpierre, Abel Zanuy, Mirelys Saenz, et al.
Chembiochem : a European Journal of Chemical Biology|October 4, 2024
Effect of O-Acetylation on the Antigenicity and Glycoconjugate Immunogenicity of the Streptococcus Pneumoniae Serotype 7F Capsular PolysaccharideJean-Pierre Soubal, Aloyma Lugo, Darielys Santana-Mederos, et al.
Bioorganic & Medicinal Chemistry|July 22, 2017
KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic libraryJorge González-Bacerio, Sarah El Chamy Maluf, Yanira Méndez, et al.
ACS Central Science|June 2, 2021
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive VaccinesYury Valdes-Balbin, Darielys Santana-Mederos, Françoise Paquet, et al.
International Journal of Biological Macromolecules|January 15, 2025
Development of a StIW111C-based bioresponsive pore-forming conjugate for permeabilizing the endosomal membraneFelipe A Escalona-Rodriguez, Javier La O-Bonet, Lidia Priscila Ferrer Tasies, et al.
European Journal of Medicinal Chemistry|December 14, 2018
Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent solid-phase synthesis of tetrazole-peptidomimeticsYanira Méndez, German De Armas, Idalia Pérez, et al.
Pageof 10